Advertisement

Topics

Cara loses a third of its share price on disappointing Phase II results

13:24 EDT 30 Jun 2017 | thePharmaLetter

Connecticut, USA-based biotech firm Cara Therapeutics has suffered a massive drop in share price after…

Original Article: Cara loses a third of its share price on disappointing Phase II results

NEXT ARTICLE

More From BioPortfolio on "Cara loses a third of its share price on disappointing Phase II results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...